Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Apr;30(4):312–316. doi: 10.1136/jcp.30.4.312

Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis.

C D Price, A R Gibbs, W J Williams
PMCID: PMC476402  PMID: 856877

Abstract

As an index of delayed hypersensitivity in vitro halothane macrophage migration inhibition factor tests (halothane-MIF tests) were performed on peripheral blood lymphocytes from five patients with halothane hepatitis. Twenty-two subjects exposed to halothane, but with no evidence of jaundice, five 'healthy' hospital anaesthetists, nine jaundiced subjects without halothane exposure, and 10 healthy subjects with no history of exposure to halothane were also tested. The halothane-MIF test was positive in four of the five patients with halothane-induced hepatitis; the negative result was in a patient on steroid treatment. The test was negative in all other subjects. Our findings suggest that the halothane-MIF test may be of value in the diagnosis of halothane-induced hepatitis and as a screeening procedure for the identification of susceptible subjects.

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURNAP T. K., GALLA S. J., VANDAM L. D. Anesthetic, circulatory and respiratory effects of fluothane. Anesthesiology. 1958 May-Jun;19(3):307–320. doi: 10.1097/00000542-195805000-00001. [DOI] [PubMed] [Google Scholar]
  2. Carney F. M., Van Dyke R. A. Halothane hepatitis: a critical review. Anesth Analg. 1972 Jan-Feb;51(1):135–160. [PubMed] [Google Scholar]
  3. Hughes M., Powell L. W. Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri. Gastroenterology. 1970 Jun;58(6):790–797. [PubMed] [Google Scholar]
  4. Inman W. H., Mushin W. W. Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines. Br Med J. 1974 Jan 5;1(5896):5–10. doi: 10.1136/bmj.1.5896.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Klatskin G., Kimberg D. V. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med. 1969 Mar 6;280(10):515–522. doi: 10.1056/NEJM196903062801001. [DOI] [PubMed] [Google Scholar]
  6. Klion F. M., Schaffner F., Popper H. Hepatitis after exposure to halothane. Ann Intern Med. 1969 Sep;71(3):467–477. doi: 10.7326/0003-4819-71-3-467. [DOI] [PubMed] [Google Scholar]
  7. Moult P. J., Sherlock S. Halothane-related hepatitis. A clinical study of twenty-six cases. Q J Med. 1975 Jan;44(173):99–114. [PubMed] [Google Scholar]
  8. Mushin W. W., Rosen M., Jones E. V. Post-halothane jaundice in relation to previous administration of halothane. Br Med J. 1971 Jul 3;3(5765):18–22. doi: 10.1136/bmj.3.5765.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. POSTOPERATIVE death after fluothane. Anesthesiology. 1958 Jul-Aug;19(4):562–563. doi: 10.1097/00000542-195807000-00018. [DOI] [PubMed] [Google Scholar]
  10. Paronetto F., Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. doi: 10.1056/NEJM197008062830602. [DOI] [PubMed] [Google Scholar]
  11. Peters R. L., Edmondson H. A., Reynolds T. B., Meister J. C., Curpey T. J. Hepatic necrosis associated with halothane anesthesia. Am J Med. 1969 Nov;47(5):748–764. doi: 10.1016/0002-9343(69)90168-5. [DOI] [PubMed] [Google Scholar]
  12. Price C. D., Williams W. J., Pugh A., Joynson D. H. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers. J Clin Pathol. 1977 Jan;30(1):24–28. doi: 10.1136/jcp.30.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SLATER E. M., GIBSON J. M., DYKES M. H., WALZER S. G. POSTOPERATIVE HEPATIC NECROSIS. ITS INCIDENCE AND DIAGNOSTIC VALUE IN ASSOCIATION WITH THE ADMINISTRATION OF HALOTHANE. N Engl J Med. 1964 May 7;270:983–987. doi: 10.1056/NEJM196405072701904. [DOI] [PubMed] [Google Scholar]
  14. Sharpstone P., Medley D. R., Williams R. Halothane hepatitis--a preventable disease? Br Med J. 1971 Feb 20;1(5746):448–450. doi: 10.1136/bmj.1.5746.448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Trowell J., Peto R., Smith A. C. Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet. 1975 Apr 12;1(7911):821–824. [PubMed] [Google Scholar]
  16. Walton B., Dumonde D. C., Williams C., Jones D., Strunin J. M., Layton J. M., Strunin L., Simpson R. Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA. 1973 Jul 30;225(5):494–498. doi: 10.1001/jama.225.5.494. [DOI] [PubMed] [Google Scholar]
  17. Walton B., Simpson B. R., Strunin L., Doniach D., Perrin J., Appleyard A. J. Unexplained hepatitis following halothane. Br Med J. 1976 May 15;1(6019):1171–1176. doi: 10.1136/bmj.1.6019.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Williams W. J., Pioli E., Jones D. J., Dighero M. The Kmif (Kveim-induced macrophage migration inhibition factor) test in sarcoidosis. J Clin Pathol. 1972 Nov;25(11):951–954. doi: 10.1136/jcp.25.11.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wright R., Eade O. E., Chisholm M., Hawksley M., Lloyd B., Moles T. M., Edwards J. C., GArdner M. J. Controlled prospective study of the effect on liver function of multiple exposures to halothane. Lancet. 1975 Apr 12;1(7911):817–820. doi: 10.1016/s0140-6736(75)93000-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES